Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Hepatology. 2019 Feb 8;69(3):1046–1063. doi: 10.1002/hep.30300

FIG. 8.

FIG. 8.

A schematic hypothetical model shows how DDX5 regulates autophagy to affect cell proliferation and tumorigenesis in HCC. DDX5 binds p62 and interferes with p62/TRAF6 interaction, suppressing mTOR signaling. MiR-17–5p inhibition upregulates DDX5 expression and promotes autophagy activity and p62 elimination, thereby suppressing cell proliferation and tumor formation.